Eris Lifesciences Limited has announced that the transcript of its Analyst and Investor call for the quarter ended June 30, 2026, is now available. Investors can access this important disclosure on the company’s official website. This transcript provides detailed insights into the company’s financial performance and future outlook following the announcement of its Q1 FY27 results.
Analyst and Investor Call Transcript Released
Eris Lifesciences Limited is providing stakeholders with access to the transcript of its recent Analyst and Investor call. This call took place following the company’s announcement of financial results for the first quarter of the Financial Year 2027, which concluded on June 30, 2026.
Accessing the Transcript
The transcript is now available for review on the company’s official website. Interested parties can find it at the following URL: https://eris.co.in/financials/. The specific file name for this document is ‘Q1 FY27 Earnings Call Transcript’. This release ensures transparency and offers investors a deeper understanding of the company’s performance and strategy discussed during the call.
Source: BSE
